From: MicroRNA-10a is reduced in breast cancer and regulated in part through retinoic acid
Breast Clinicopathological characteristics | Cancer | Fibroadenoma | Normal |
---|---|---|---|
Number of patients | 103 | 35 | 30 |
Median Patient Age yrs | 56 (35ā90) | 44 (17ā62) | 46.5 (24ā58) |
Menopausal Status | Ā | Ā | Ā |
Post | 72 | Ā | Ā |
Pre | 32 | Ā | Ā |
Histological Subtype | Ā | Ā | Ā |
Invasive Ductal | 78 | Ā | Ā |
Invasive Lobular | 11 | Ā | Ā |
Other | 14 | Ā | Ā |
Intrinsic Subtype | Ā | Ā | Ā |
Luminal A (ER/PR+, HER2/neu-) | 42 | Ā | Ā |
Luminal B (ER/PR+, HER2/neu+) | 18 | Ā | Ā |
HER2 Over expressing (ER-, PR-, HER2/neu+) | 16 | Ā | Ā |
Triple-Negative (ER-, PR-, HER2/neu-) | 16 | Ā | Ā |
Unknown | 11 | Ā | Ā |
Tumour Grade | Ā | Ā | Ā |
1 | 5 | Ā | Ā |
2 | 32 | Ā | Ā |
3 | 55 | Ā | Ā |
Tumour size | Ā | Ā | Ā |
1 | 19 | Ā | Ā |
2 | 39 | Ā | Ā |
3 | 10 | Ā | Ā |
UICC Stage | Ā | Ā | Ā |
Stage 1 | 23 | Ā | Ā |
Stage 2 | 36 | Ā | Ā |
Stage 3 | 21 | Ā | Ā |
Stage 4 | 10 | Ā | Ā |